Our Financial Efficiency and Responsibility
At JDRF, we are part of the very community we support. This makes us passionately driven to cure T1D and improve the lives of everyone impacted by this disease. This also makes us personal stewards of every donation made to JDRF and drives us to make each donation bigger by attracting the expertise and additional funding from other organizations and partners. In fiscal year 2020, we pulled in another $3.50 for every $1 that JDRF committed to research. We steward every donation and maximize its impact.
Learn more about JDRF’s Impact through our Research and Advocacy efforts.
By diversifying and innovating our fundraising model, we have continued to drive funds to T1D research. Due to the coronavirus pandemic, we experienced slight decreases from FY19 to FY20 (between 7% and 9%) in Total JDRF Research Support, Support of Mission, and Total Revenue. During this same timeframe, the sum of our Total Research Support and Leveraged Funds for T1D Research continued to increase each year. In FY20, our efforts had a greater impact as we leveraged more global support for T1D research and therapy development than ever before.
JDRF International uses direct appeals to drive a call to action for optimal healthcare for people living with T1D, as well as public policy advocacy. This education and information delivery is inherent in our mission statement—leading the fight against T1D by funding research, advocating for policies that accelerate access to new therapies, and providing a support network for millions of people around the world impacted by T1D. As a result, in accordance with the Financial Accounting Standards Board (FASB) guideline and Internal Revenue Service (IRS) guidelines, we allocate a portion of our direct appeal costs to program services.
Download our One Page document [PDF] outlining how JDRF maximizes each donation by attracting additional funding for cures research
and advances to improve lives.
Financial documents
Our tax identification number is 23-1907729.
JDRF is a charitable organization with tax-exempt status granted under Section 501(c)(3) of the U.S. Internal Revenue Code. All chapters and branches are covered under this umbrella. Donations to JDRF are tax-deductible to the full extent allowed by law.
Annual Reports
- Annual Report 2020 | Donor Honor Roll
- Annual Report 2019 | Donor Honor Roll
- Annual Report 2018 | Donor Honor Roll
- Annual Report 2017 | Donor Honor Roll
Audited Financial Statements
- Audited Financial Statements 2020
- Audited Financial Statements 2019
- Audited Financial Statements 2018
- Audited Financial Statements 2017
IRS Form 990
- IRS Form 990 FY20 (form Year 2019)
- IRS Form 990 FY19 (form Year 2018)
- IRS Form 990 FY18 (Form Year 2017)
- IRS Form 990 FY17 (Form Year 2016)
Additional tax information
- 501(c)(3) Exemption Determination Letter from IRS
- JDRF International Letter of Good Standing
- JDRF Form W-9
Nevada Drug Transparency Compliance Report
JDRF’s funding comes from many sources, the vast majority from the millions of people affected by T1D. Any contribution from pharmaceutical companies and device manufacturers is small compared to what we raise directly from the T1D community.